Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3632-3642

  Amante, Fiona H ^a,b   Haque, Ashraful ^a,b   Stanley, Amanda C ^a,b   Rivera, Fabian De Labastida ^a,b   Randall, Louise M ^a,b,c   Wilson, Yana A ^a,b   Yeo, Gladys ^a,b,c   Pieper, Christian ^a,b,f   Crabb, Brendan S ^d   De Koning Ward, Tania F ^e   Lundie, Rachel J ^g   Good, Michael F ^a,b   Pinzon Charry, Alberto ^a,b   Pearson, Mark S ^a,b   Duke, Mary G ^a,b   McManus, Donald P ^a,b   Loukas, Alex ^a,b   Hill, Geoff R ^a,b   Engwerda, Christian R ^a  

^a Australian Centre for Vaccine Development   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d BURNET INSTITUTE   (Australia)

^e DEAKIN UNIVERSITY   (Australia)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LYMPHOTOXIN ALPHA BETA; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN; BRAIN MALARIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HELMINTH; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LUNG; MICROBIAL BIOMASS; MIXED INFECTION; MOUSE; NONHUMAN; PARASITE TISSUE SEQUESTRATION; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC ORGANISM;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FEMALE; GASTROINTESTINAL TRACT; KIDNEY; LIVER; LUNG; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; ORGAN SPECIFICITY; PLASMODIUM BERGHEI; SEVERITY OF ILLNESS INDEX; SPLEEN;

EID: 78649848029     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000944     Document Type: Article

References (72)

1. World Health Organization. 2009. World Malaria Report. World Health Organization, Geneva, Switzerland.
2. MacPherson, G. G., M. J. Warrell, N. J. White, S. Looareesuwan, and D. A. Warrell. 1985. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119: 385-401.
3. Berendt, A. R., G. D. Tumer, and C. I. Newbold. 1994. Cerebral malaria: the sequestration hypothesis. Parasitol. Today 10: 412-414.
4. Engwerda, C. R., L. Beattie, and F. H. Amante. 2005. The importance of the spleen in malaria. Trends Parasitol. 21: 75-80.
5. Newton, C. R., and S. Krishna. 1998. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol. Ther. 79: 1-53.
6. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5: 722-735.
7. Good, M. F., H. Xu, M. Wykes, and C. R. Engwerda. 2005. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. 23: 69-99.
8. Rénia, L., S. M. Potter, M. Mauduit, D. S. Rosa, M. Kayibanda, J. C. Deschemin, G. Snounou, and A. C. Grüner. 2006. Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 36: 547-554.
9. Clark, I. A., and W. B. Cowden. 2003. The pathophysiology of falciparum malaria. Pharmacol. Ther. 99: 221-260.
10. van der Heyde, H. C., J. Nolan, V. Combes, I. Gramaglia, and G. E. Grau. 2006. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22: 503-508.
11. Engwerda, C., E. Belnoue, A. C. Grüner, and L. Rénia. 2005. Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 297: 103-143.
12. Hermsen, C., T. van de Wiel, E. Mommers, R. Sauerwein, and W. Eling. 1997. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology 114: 7-12.
13. Grau, G. E., P. F. Piguet, H. D. Engers, J. A. Louis, P. Vassalli, and P. H. Lambert. 1986. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 137: 2348-2354.
14. Nitcheu, J., O. Bonduelle, C. Combadiere, M. Tefit, D. Seilhean, D. Mazier, and B. Combadiere. 2003. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170: 2221-2228.
15. Yañez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157: 1620-1624.
16. Curfs, J. H., T. P. Schetters, C. C. Hermsen, C. R. Jerusalem, A. A. van Zon, and W. M. Eling. 1989. Immunological aspects of cerebral lesions in murine malaria. Clin. Exp. Immunol. 75: 136-140.
17. Hermsen, C. C., E. Mommers, T. van de Wiel, R. W. Sauerwein, and W. M. Eling. 1998. Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J. Infect. Dis. 178: 1225-1227.
18. Lundie, R. J., T. F. de Koning-Ward, G. M. Davey, C. Q. Nie, D. S. Hansen, L. S. Lau, J. D. Mintern, G. T. Belz, L. Schofield, F. R. Carbone, et al. 2008. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc. Natl. Acad. Sci. USA 105: 14509-14514.
19. Miyakoda, M., D. Kimura, M. Yuda, Y. Chinzei, Y. Shibata, K. Honma, and K. Yui. 2008. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J. Immunol. 181: 1420-1428.
20. Potter, S., T. Chan-Ling, H. J. Ball, H. Mansour, A. Mitchell, L. Maluish, and N. H. Hunt. 2006. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int. J. Parasitol. 36: 485-496.
21. Potter, S., G. Chaudhri, A. Hansen, and N. H. Hunt. 1999. Fas and perforin contribute to the pathogenesis of murine cerebral malaria. Redox Rep. 4: 333-335.
22. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210-1212.
23. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P. H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86: 5572-5574.
24. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371-1377.
25. Hunt, N. H., J. Golenser, T. Chan-Ling, S. Parekh, C. Rae, S. Potter, I. M. Medana, J. Miu, and H. J. Ball. 2006. Immunopathogenesis of cerebral malaria. Int. J. Parasitol. 36: 569-582.
26. Langhorne, J., B. Simon-Haarhaus, and S. J. Meding. 1990. The role of CD4+ T cells in the protective immune response to Plasmodium chabaudi in vivo. Immunol. Lett. 25: 101-107.
27. Podoba, J. E., and M. M. Stevenson. 1991. CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect. Immun. 59: 51-58.
28. Ockenhouse, C. F., S. Schulman, and H. L. Shear. 1984. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J. Immunol. 133: 1601-1608.
29. Shear, H. L., R. Srinivasan, T. Nolan, and C. Ng. 1989. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts. J. Immunol. 143: 2038-2044.
30. Bouharoun-Tayoun, H., P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe. 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172: 1633-1641.
31. Mota, M. M., K. N. Brown, A. A. Holder, and W. Jarra. 1998. Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro. Infect. Immun. 66: 4080-4086.
32. Shear, H. L., R. S. Nussenzweig, and C. Bianco. 1979. Immune phagocytosis in murine malaria. J. Exp. Med. 149: 1288-1298.
33. Waki, S., S. Uehara, K. Kanbe, H. Nariuch, and M. Suzuki. 1995. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice. Parasite Immunol. 17: 503-508.
34. Silamut, K., N. H. Phu, C. Whitty, G. D. Turner, K. Louwrier, N. T. Mai, J. A. Simpson, T. T. Hien, and N. J. White. 1999. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am. J. Pathol. 155: 395-410.
35. Dondorp, A. M., V. Desakorn, W. Pongtavornpinyo, D. Sahassananda, K. Silamut, K. Chotivanich, P. N. Newton, P. Pitisuttithum, A. M. Smithyman, N. J. White, and N. P. Day. 2005. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2: e204.
36. Chang, W. L., S. P. Jones, D. J. Lefer, T. Welbourne, G. Sun, L. Yin, H. Suzuki, J. Huang, D. N. Granger, and H. C. van der Heyde. 2001. CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect. Immun. 69: 7341-7348.
37. Lovegrove, F. E., S. A. Gharib, L. Peña-Castillo, S. N. Patel, J. T. Ruzinski, T. R. Hughes, W. C. Liles, and K. C. Kain. 2008. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 4: e1000068.
38. Amante, F. H., A. C. Stanley, L. M. Randall, Y. Zhou, A. Haque, K. McSweeney, A. P. Waters, C. J. Janse, M. F. Good, G. R. Hill, and C. R. Engwerda. 2007. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 171: 548-559.
39. Franke-Fayard, B., C. J. Janse, M. Cunha-Rodrigues, J. Ramesar, P. Büscher, I. Que, C. Löwik, P. J. Voshol, M. A. den Boer, S. G. van Duinen, et al. 2005. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. USA 102: 11468-11473.
40. Nie, C. Q., N. J. Bernard, M. U. Norman, F. H. Amante, R. J. Lundie, B. S. Crabb, W. R. Heath, C. R. Engwerda, M. J. Hickey, L. Schofield, and D. S. Hansen. 2009. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 5: e1000369.
41. Randall, L. M., F. H. Amante, K. A. McSweeney, Y. Zhou, A. C. Stanley, A. Haque, M. K. Jones, G. R. Hill, G. M. Boyle, and C. R. Engwerda. 2008. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Infect. Immun. 76: 3312-3320.
42. Randall, L. M., F. H. Amante, Y. Zhou, A. C. Stanley, A. Haque, F. Rivera, K. Pfeffer, S. Scheu, G. R. Hill, K. Tamada, and C. R. Engwerda. 2008. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA. J. Immunol. 181: 7458-7462.
43. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
44. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
45. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
46. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
47. Sean Riminton, D., H. Körner, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187: 1517-1528.
48. Körner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Köntgen, B. Fazekas de St Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27: 2600-2609.
49. Janse, C. J., J. Ramesar, and A. P. Waters. 2006. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat. Protoc. 1: 346-356.
50. Tran, M. H., M. S. Pearson, J. M. Bethony, D. J. Smyth, M. K. Jones, M. Duke, T. A. Don, D. P. McManus, R. Correa-Oliveira, and A. Loukas. 2006. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat. Med. 12: 835-840.
51. Su, Z., M. Segura, K. Morgan, J. C. Loredo-Osti, and M. M. Stevenson. 2005. Impairment of protective immunity to blood-stage malaria by concurrent nematode infection. Infect. Immun. 73: 3531-3539.
52. Su, Z., M. F. Tam, D. Jankovic, and M. M. Stevenson. 2003. Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice. Infect. Immun. 71: 5178-5187.
53. Markey, K. A., A. C. Burman, T. Banovic, R. D. Kuns, N. C. Raffelt, V. Rowe, S. D. Olver, A. L. Don, E. S. Morris, A. R. Pettit, et al. 2009. Soluble lymphotoxin is an important effector molecule in GVHD and GVL. Blood 115: 122-132.
54. Mintern, J., M. Li, G. M. Davey, E. Blanas, C. Kurts, F. R. Carbone, and W. R. Heath. 1999. The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol. Cell Biol. 77: 539-543.
55. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
56. Beeson, J. G., and G. V. Brown. 2002. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell. Mol. Life Sci. 59: 258-271.
57. Belnoue, E., M. Kayibanda, A. M. Vigario, J. C. Deschemin, N. van Rooijen, M. Viguier, G. Snounou, and L. Rénia. 2002. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169: 6369-6375.
58. Hartgers, F. C., and M. Yazdanbakhsh. 2006. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol. 28: 497-506.
59. Pearce, E. J., and A. S. MacDonald. 2002. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2: 499-511.
60. Wassmer, S. C., V. Combes, F. J. Candal, I. Juhan-Vague, and G. E. Grau. 2006. Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect. Immun. 74: 645-653.
61. Kossodo, S., C. Monso, P. Juillard, T. Velu, M. Goldman, and G. E. Grau. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91: 536-540.
62. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194: 1497-1506.
63. Mwangi, T. W., J. M. Bethony, and S. Brooker. 2006. Malaria and helminth interactions in humans: an epidemiological viewpoint. Ann. Trop. Med. Parasitol. 100: 551-570.
64. Druilhe, P., A. Tall, and C. Sokhna. 2005. Worms can worsen malaria: towards a new means to roll back malaria? Trends Parasitol. 21: 359-362.
65. Waknine-Grinberg, J. H., D. Gold, A. Ohayon, E. Flescher, A. Heyfets, M. J. Doenhoff, G. Schramm, H. Haas, and J. Golenser. 2010. Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malar. J. 9: 5.
66. Haque, A., and M. F. Good. 2009. Malaria vaccine research: lessons from 2008/9. Future Microbiol. 4: 649-654.
67. Good, M. F. 2009. The hope but challenge for developing a vaccine that might control malaria. Eur. J. Immunol. 39: 939-943.
68. Greenwood, B., and G. Targett. 2009. Do we still need a malaria vaccine? Parasite Immunol. 31: 582-586.
69. Schofield, L. 2007. Rational approaches to developing an anti-disease vaccine against malaria. Microbes Infect. 9: 784-791.
70. Hirunpetcharat, C., and M. F. Good. 1998. Deletion of Plasmodium bergheispecific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite. Proc. Natl. Acad. Sci. USA 95: 1715-1720.
71. Xu, H., J. Wipasa, H. Yan, M. Zeng, M. O. Makobongo, F. D. Finkelman, A. Kelso, and M. F. Good. 2002. The mechanism and significance of deletion of parasitespecific CD4(+) T cells in malaria infection. J. Exp. Med. 195: 881-892.
72. Achtman, A. H., P. C. Bull, R. Stephens, and J. Langhorne. 2005. Longevity of the immune response and memory to blood-stage malaria infection. Curr. Top. Microbiol. Immunol. 297: 71-102.